MIT scientists have developed a prototype device that allows chemotherapy patients to test their white blood cell levels without pricking a finger or taking a blood sample.
A new device called Fiberscope could help scientists with their searches by giving them a less-invasive look into the brain’s depths.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Scientists and bioengineers are warming up to cryogenic electron microscopy (cryo-EM), an ultra-low-temperature technique for visualizing the atomic-level inner workings of human cells and other applications.
After a decade of work in his lab at the Howard Hughes Medical Institute, Eric Betzig has developed a microscope that presents an unprecedented picture of subcellular activity in 3D living color.
Engineers and physicians have developed a camera inspired by a butterfly’s eye to distinguish between tumors and healthy tissue in breast cancer patients. The system could help surgeons detect and remove cancerous tissue more effectively than current technologies.
Risk of infection continues to be an issue across the healthcare arena. A Frost & Sullivan industry research study published in May 2017 reported that global revenue in the antimicrobial coating materials market stood at $700 million in 2016, and is poised to reach $1.1 billion by 2021.
A new technology's integrated software system reduces the usual unhelpful variations in tumor measurement and could well translate to more lives saved, say its developers.
The landscape is constantly evolving for imaging technology and biomarkers, and how they impact cancer detection and treatment. Frost & Sullivan has provided AABME with market intelligence on key innovations for imaging and biomarker technology for oncology.
We are almost ready to share the next AABME white paper, Genome Editing and Biomanufacturing, by Gang Bao, a pioneer in nanomedicine, molecular imaging, and the emerging area of genome editing.
A new detector for scanning transmission electron microscopes may help researchers develop more effective drugs and map how cancer spreads from cell to cell, or enable them to probe the causes of other cell-based diseases.
New radiopharmaceuticals, technologies, products, and software are driving adoption in an increasingly uncertain healthcare environment.
A microscope the size of a pen could help surgeons with difficult-to-remove tumors and cancers.
Studying the binding and unbinding of molecules could lead to better insights into the study of antibodies.
Researchers at Tel-Aviv University have shown how the brain activity behind stress and fear can be turned down with biofeedback.